< Back to scientific publications

Magazine 2.4

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Authors: lionetti R

Date: May 2019

Scope of interest: infectious/hepatological




You may also be interested in:

Magazine 14.6

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

Authors: Cucchetti A

Date: Aug 2014

Scope of interest: hepatological


Read details
Magazine 3,264

Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging

Authors: Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM, Marcheselli F, Monti D, Ostan R, Cevenini E, Antonicelli R, Franceschi C, Procopio AD

Date: 2012

Scope of interest: ageing, geriatrics


Read details
Magazine 15.26

ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.

Authors: Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, Pedroso JL, Terracciano C, Caltagirone C, et al

Date: 2016

Scope of interest: Neurogenetics


Read details